These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38087188)

  • 21. Primary aldosteronism - treatment options.
    Young WF
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S102-8. PubMed ID: 12914736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of aldosterone-producing adenoma on cardiac structures in echocardiography.
    Hidaka T; Shiwa T; Fujii Y; Nishioka K; Utsunomiya H; Ishibashi K; Mitsuba N; Dohi Y; Oda N; Noma K; Kurisu S; Nakano Y; Yamamoto H; Iishida T; Higashi Y; Kihara Y
    J Echocardiogr; 2013; 11(4):123-9. PubMed ID: 24319340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
    Nakamaru R; Yamamoto K; Akasaka H; Rakugi H; Kurihara I; Yoneda T; Ichijo T; Katabami T; Tsuiki M; Wada N; Yamada T; Kobayashi H; Tamura K; Ogawa Y; Kawashima J; Inagaki N; Fujita M; Watanabe M; Kamemura K; Okamura S; Tanabe A; Naruse M;
    Sci Rep; 2021 Mar; 11(1):6925. PubMed ID: 33767283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
    Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
    Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
    Kim IY; Park IS; Kim MJ; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH; Chung HC
    Int Urol Nephrol; 2018 Oct; 50(10):1887-1895. PubMed ID: 29779118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
    Kater CE; Biglieri EG
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role.
    Sabbadin C; Ceccato F; Ragazzi E; Boscaro M; Betterle C; Armanini D
    J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1313-1318. PubMed ID: 30058103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.
    Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Umakoshi H; Ichijo T; Katabami T; Wada N; Ogawa Y; Yoshimoto T; Kawashima J; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Miyauchi S; Kamemura K; Fukuoka T; Yamamoto K; Otsuki M; Suzuki T; Naruse M;
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4456-4464. PubMed ID: 30165444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
    Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
    Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
    An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenoma.
    Wang W; Wei F; Li R; Tian J
    Medicine (Baltimore); 2019 Oct; 98(43):e17418. PubMed ID: 31651844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F; Mattarello MJ; Albiger NM
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
    Amar L; Lorthioir A; Azizi M; Plouin PF
    Eur J Endocrinol; 2015 Mar; 172(3):R125-9. PubMed ID: 25315875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal damage in primary aldosteronism: results of the PAPY Study.
    Rossi GP; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mannelli M; Matterello MJ; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Pessina AC; Mantero F;
    Hypertension; 2006 Aug; 48(2):232-8. PubMed ID: 16801482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
    Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.
    Kim DH; Kwon HJ; Ji SA; Jang HR; Jung SH; Kim JH; Kim JH; Lee JE; Huh W; Kim YG; Kim DJ; Oh HY
    Medicine (Baltimore); 2016 Jul; 95(27):e3930. PubMed ID: 27399066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
    Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.